Resumo
Definição
History and exam
Key diagnostic factors
- tachycardia
- tachypnea
- high (>101°F [>38°C]) or low (<96.8°F [<36°C]) temperature
- acutely altered mental status
- low oxygen saturation
- arterial hypotension
- decreased urine output
- poor capillary refill, mottling of the skin, or ashen appearance
- signs associated with specific source of infection
- cyanosis
Other diagnostic factors
- malaise/lethargy
- nausea/vomiting/diarrhea
- purpura fulminans
- jaundice
- ileus
Risk factors
- age >65 years
- immunocompromised state
- indwelling intravenous lines or urinary catheters
- recent surgery or other invasive procedures
- hemodialysis
- diabetes mellitus
- intravenous drug use
- alcohol use disorder
- breached skin integrity
- pregnancy
- urban residence
- lung disease
- male sex
- non-white ancestry
- winter season
Diagnostic tests
1st tests to order
- blood culture
- lactate levels
- CBC with differential
- blood urea nitrogen (BUN) and serum electrolytes
- serum creatinine
- liver function tests
- coagulation studies (INR, activated PTT, fibrinogen)
- serum glucose
- C-reactive protein (CRP) or procalcitonin (PCT)
- other cultures (e.g., of sputum, stool, urine, wounds, catheters, prosthetic implants, epidural sites, pleural or peritoneal fluid)
- arterial blood gas (ABG) or venous blood gas (VBG)
- chest x-ray
- ECG
Tests to consider
- lumbar puncture
- echocardiogram (transthoracic or transesophageal)
- ultrasound scan
- CT chest or abdomen
Treatment algorithm
presumed or confirmed sepsis
Contributors
Expert advisers
Andre C. Kalil, MD, MPH, FACP, FIDSA, FCCM
Professor
Department of Internal Medicine
Division of Infectious Diseases
University of Nebraska Medical Center
Omaha, NE
Disclosures
ACK declares that he has no competing interests.
Kelly Cawcutt, MD, MS, FACP, FIDSA, FCCM
Associate Professor
Department of Internal Medicine
Division of Pulmonary, Critical Care, Sleep & Allergy
University of Nebraska Medical Center
Omaha, NE
Disclosures
KC has received payment for medical writing from IDSA and CloroxPro. KC has received honoraria for creation of educational materials from the Society for Healthcare Epidemiology of America (SHEA) and payment from BD. KC has received honoraria and travel expenses from NAPA. KC has received payment for book proposal review from Elsevier. KC has participated as author, lecturer, and committee member for the Society of Critical Care Medicine (SCCM) course and book, providing content on controversies in sepsis.
Acknowledgements
Professor Andre Kalil and Dr Kelly Cawcutt would like to gratefully acknowledge Dr Ron Daniels, Dr Matt Inada-Kim, Dr Aamir Saifuddin, Dr Tim Nutbeam, Dr Edward Berry, Dr Lewys Richmond, and Dr Paul Kempen, previous contributors to this topic.
Disclosures
RD has received payment for consultancy on sepsis from Kimal Plc, manufacturers of vascular access devices; from the Northumbria Partnership, a patient safety collaborative; and, where annual leave or other income was compromised in fulfilling his charity duties, from the UK Sepsis Trust. RD has received sponsorship to attend and speak at one meeting from Abbott Diagnostics. He is CEO of the UK Sepsis Trust and Global Sepsis Alliance, and advises HM Government, the World Health Organization, and NHS England on sepsis. Each of these positions demands that he express opinion on strategies around the recognition and management of sepsis. MIK is a national clinical advisor on sepsis to NHS England and a national clinical advisor on deterioration to NHS Improvement. He was reimbursed for a slide set by Relias Learning. AS is the clinical fellow to the National Medical Director at NHS Improvement. AS has been sponsored on two occasions by Dr Falk Pharma UK to attend specialist gastroenterology conferences abroad; there was no contractual obligation to disseminate product information. TN is a clinical adviser to the UK Sepsis Trust. EB, LR, and PK declare that they have no competing interests.
Peer reviewers
Laura Evans, MD, MSc, FCCP, FCCM
Associate Professor
NYU School of Medicine
Medical Director of Critical Care
Bellevue Hospital Center
New York, NY
Declarações
LE serves as the guidelines co-chair and on the steering committee of the Surviving Sepsis Campaign.
Créditos aos pareceristas
Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.
Declarações
As afiliações e declarações dos pareceristas referem--se ao momento da revisão.
Referências
Principais artigos
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016 Feb 23;315(8):801-10.Texto completo Resumo
Prescott HC, Antonelli M, Alhazzani W, et al. Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026. Crit Care Med. 2026 Apr 1;54(4):725-812.Texto completo Resumo
National Institute for Health and Care Excellence. Suspected sepsis in people aged 16 or over: recognition, assessment and early management. Nov 2025 [internet publication].Texto completo
Gauer R, Forbes D, Boyer N. Sepsis: diagnosis and management. Am Fam Physician. 2020 Apr 1;101(7):409-18.Texto completo Resumo
Artigos de referência
Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

Diagnósticos diferenciais
- Noninfectious causes of systemic inflammatory response syndrome (SIRS)
- Myocardial infarction (MI)
- Pericarditis
Mais Diagnósticos diferenciaisDiretrizes
- Surviving Sepsis Campaign: international guidelines for management of sepsis and septic shock 2026
- Suspected sepsis in people aged 16 or over: recognition, assessment and early management
Mais DiretrizesCalculadoras
Sequential Organ Failure Assessment: SOFA Score
APACHE II scoring system
Mais CalculadorasVideos
Diagnostic lumbar puncture in adults: animated demonstration
Venepuncture and phlebotomy: animated demonstration
Mais vídeosFolhetos informativos para os pacientes
Sepsis in adults
Intravenous catheter (cannula) insertion
Mais Folhetos informativos para os pacientesConectar-se ou assinar para acessar todo o BMJ Best Practice
O uso deste conteúdo está sujeito ao nosso aviso legal